Vivos Therapeutics (VVOS) EBITDA (2020 - 2026)
Vivos Therapeutics (VVOS) reported EBITDA of -$6.3 million for Q1 2026, down 69.85% year-over-year from -$20.9 million in Q1 2025, and up 4.06% on a QoQ basis from -$6.6 million in Q4 2025.
Vivos Therapeutics (VVOS) has 7 years of EBITDA data on file, last reported at -$6.3 million in Q1 2026.
- Quarterly EBITDA fell 69.85% year-over-year to -$6.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.8 million (down 101.72% YoY) and the FY2025 annual result came in at -$19.2 million, down 79.87% from the prior year.
- EBITDA advanced to -$6.3 million in Q1 2026 per VVOS's latest filing, from -$6.6 million in the prior quarter.
- Across five years, EBITDA topped out at -$1.8 million in Q2 2024 and bottomed at -$6.8 million in Q2 2022.
- The 5-year median for EBITDA is -$4.4 million (2023), against an average of -$4.5 million.
- The widest annual swing landed in 2022, when EBITDA plunged 165.41%; it then jumped 58.43% in 2024.
- Tracing VVOS's EBITDA over 5 years: stood at -$5.8 million in 2022, then surged by 31.75% to -$3.9 million in 2023, then jumped by 31.2% to -$2.7 million in 2024, then plunged by 143.24% to -$6.6 million in 2025, then rose by 4.06% to -$6.3 million in 2026.
- Per Business Quant, the three latest VVOS EBITDA figures stand at -$6.3 million (Q1 2026), -$6.6 million (Q4 2025), and -$4.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 663.81 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | -6.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.32 Mn |
| Dec 31, 2025 | -6.58 Mn |
| Sep 30, 2025 | -4.33 Mn |
| Jun 30, 2025 | -4.57 Mn |
| Mar 31, 2025 | -3.72 Mn |
| Dec 31, 2024 | -2.71 Mn |
| Sep 30, 2024 | -2.55 Mn |
| Jun 30, 2024 | -1.84 Mn |
| Mar 31, 2024 | -3.69 Mn |
| Dec 31, 2023 | -3.93 Mn |
| Sep 30, 2023 | -3.54 Mn |
| Jun 30, 2023 | -4.42 Mn |
| Mar 31, 2023 | -4.81 Mn |
| Dec 31, 2022 | -5.76 Mn |
| Sep 30, 2022 | -5.21 Mn |
| Jun 30, 2022 | -6.76 Mn |
| Mar 31, 2022 | -6.44 Mn |
| Dec 31, 2021 | 8.81 Mn |
| Sep 30, 2021 | -5.40 Mn |
| Jun 30, 2021 | -3.98 Mn |
| Mar 31, 2021 | -3.31 Mn |
| Dec 31, 2020 | -6.26 Mn |
| Sep 30, 2020 | -1.66 Mn |
| Jun 30, 2020 | -1.34 Mn |
| Mar 31, 2020 | -2.48 Mn |